At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $487M
Founded date: 2021
Investors 6
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | OrbiMed | orbimed.co... |
| - | HBM Partne... | hbmpartner... |
| - | Catalio Ca... | cataliocap... |
| - | Balderton ... | balderton.... |
| 09.12.2021 | SR One | srone.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.12.2023 | Series C | $101M | - |
| 17.10.2022 | Series B | $168M | Logos Capi... |
| 08.12.2021 | Series A | $218M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 05.12.2023 | Odyssey Therapeutics Raises $101M in Series C Financing | Odyssey Therapeutics, a Boston, MA-based biotechnology company developing precision immunomodulators... | finsmes.co... |
| 13.10.2022 | Odyssey Therapeutics Raises $168M in Series B Financing | Odyssey Therapeutics, a Boston, MA-based biotechnology company, raised $168M in Series B funding. T... | finsmes.co... |
| 13.10.2022 | 10 months after first mega round, Glick's Odyssey raises $16... | The Odyssey Therapeutics story is progressing quickly. Ten months after disclosing a $218 million se... | fiercebiot... |
| 13.10.2022 | Odyssey Therapeutics Announces Oversubscribed $168 Million S... | - | orbimed.co... |
| 25.04.2022 | London’s BenevolentAI lists on Euronext Amsterdam to boost d... | London-headquartered clinical-stage AI-enabled drug discovery company, BenevolentAI has begun tradin... | tech.eu/20... |
| 08.12.2021 | Odyssey Therapeutics Raises $218M in Series A Financing | Odyssey Therapeutics, a Boston MA-based biotechnology company advancing next generation precision im... | finsmes.co... |
| - | Odyssey Therapeutics | “Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for... | fastfounde... |
| - | Odyssey Therapeutics | “Odyssey Therapeutics is making epic leaps in inflammation and oncology medicines by innovating with... | fastfounde... |
| - | Rahko acquired by Odyssey Therapeutics | Rahko was founded in 2018 by Leonard Wossnig, Ph.D., Edward Grant, Ph.D., Miriam Cha, and Ian Horobi... | balderton.... |
| - | London’s BenevolentAI lists on Euronext Amsterdam to boost d... | London-headquartered clinical-stage AI-enabled drug discovery company, BenevolentAI has begun tradin... | tech.eu/20... |